WHITE PAPER
Renewed Interest in Clinical Research Helps Change the Conversation about Trial Participation
New survey shows participant interest in clinical research at an all-time high, but it could dissipate if the biopharma industry doesn't act.
Feb 17, 2022

Over the last year consumers have monitored the development of vaccines and treatments created to address the COVID-19 pandemic, which could point to a rising interest in trial participation. Living through and monitoring the development of vaccines engaged consumers with the research process, which could be a bonus for future recruiting efforts.

This white paper focuses on recent consumer openness towards clinical research and how it represents an exciting opportunity for the biopharma industry to engage with patient communities and accelerate research. In this paper, contributing authors from IQVIA discuss ways in which our industry can drive awareness to keep the momentum going regarding participating in clinical research by highlighting the benefits it brings to the entire community.

Related solutions

Contact Us